NYSE · ULSTechnologyTesting Laboratories

UL Solutions financials

$64.92+0.19%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
Revenue$3.05B$2.87B
Gross profit$1.51B$1.39B
Gross margin49.5%48.5%
Operating income$522.0M$462.0M
Net income$325.0M$326.0M
Net margin10.6%11.4%
Diluted EPS$1.60$1.62
EBITDA$745.0M$633.0M
Operating cash flow$600.0M$524.0M
Free cash flow$403.0M$287.0M
Diluted shares203.0M201.0M

Balance sheet

Period endDec 31Dec 31
Cash & equivalents$295.0M$298.0M
Short-term investments$0.00$0.00
Total debt$491.0M$742.0M
Total assets$2.92B$2.80B
Total liabilities$1.63B$1.87B
Shareholders' equity$1.29B$931.0M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology